or Try an Advanced Search...

    Technical Analysis for OGN - Organon & Co.

    Grade Last Price % Change Price Change
    A 18.61 -1.53% -0.29
    OGN closed down 1.53 percent on Tuesday, April 30, 2024, on approximately normal volume. Note that the stock is in overbought territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or a pulls back.
    Earnings due: May 2
    *** please verify all earnings dates ***
    2 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Up Up Up
    Historical OGN trend table...
    Date Alert Name Type % Chg
    Slingshot Bullish Bullish Swing Setup 0.00%
    Overbought Stochastic Strength 0.00%
    Upper Bollinger Band Touch Strength 0.00%
    Above Upper BB Strength -1.53%
    Gapped Up Strength -1.53%
    Overbought Stochastic Strength -1.53%
    Upper Bollinger Band Touch Strength -1.53%
    Stochastic Sell Signal Bearish 0.32%
    Inside Day Range Contraction 0.32%
    Overbought Stochastic Strength 0.32%
    Older End-of-Day Signals for OGN ...

       Recent Intraday Alerts

    Alert Time
    60 Minute Opening Range Breakdown about 10 hours ago
    Possible NR7 about 11 hours ago
    1.5x Volume Pace about 15 hours ago
    Fell Below Previous Day's Low about 15 hours ago
    Down 1% about 15 hours ago
    View Earlier Intraday Alerts

    Free Daily (Stock) Chart Reading

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Track My Stocks
    Configure default chart indicators
    OGN Chart by TradingView
    Basic chart:

    Profile

    Organon & Co., a science-based pharmaceutical company, develops and delivers health solutions through a portfolio of prescription therapies within women's health, biosimilars, and established brands. Organon & Co. was incorporated in 2020 and is based in Jersey City, New Jersey. Organon & Co. operates independently of Merck & Co., Inc. as of June 2, 2021.
    Classification
    Sector: Healthcare
    Industry: Drug Manufacturers - General
    Keywords: Life Sciences Pharmaceutical Health Care Health Solutions Biosimilar Science Based Pharmaceutical

    Is OGN a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 3 bullish, 0 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Apr 25 Earnings Preview: Organon (OGN) Q1 Earnings Expected to Decline
    Apr 13 AbbVie keeps Humira market share near 100% despite biosimilars: report
    Apr 8 Organon To Report First Quarter 2024 Results and Host Conference Call on May 2, 2024
    Apr 8 Phase 3 Comparative Clinical Study of Prolia® and Xgeva® (denosumab) Biosimilar Candidate HLX14 Met Primary Endpoints
    Mar 8 On International Women's Day, Organon Canada is encouraging businesses to Invest in HER and help address gender inequities through women's health
    Feb 24 Organon Stock Is Still Worth A Look
    Feb 20 Organon Announces HADLIMA™ (adalimumab-bwwd) Has Been Exclusively Selected by the US Department of Veterans Affairs (VA), Replacing HUMIRA on Its National Formulary
    Feb 16 Organon Q4 And Full Year 2023 Earnings Review - Positive Updates At Last
    Feb 15 Why Herbalife Shares Are Trading Lower By Around 36%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
    Feb 15 Organon & Co. (OGN) Q4 2023 Earnings Call Transcript
    See more OGN news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 22.9893
    52 Week Low 10.6715
    Average Volume 2,163,501
    200-Day Moving Average 16.75
    50-Day Moving Average 18.12
    20-Day Moving Average 18.14
    10-Day Moving Average 18.33
    Average True Range 0.50
    RSI (14) 56.71
    ADX 14.61
    +DI 24.27
    -DI 17.43
    Chandelier Exit (Long, 3 ATRs) 17.54
    Chandelier Exit (Short, 3 ATRs) 18.83
    Upper Bollinger Bands 18.90
    Lower Bollinger Band 17.39
    Percent B (%b) 0.81
    BandWidth 8.35
    MACD Line 0.18
    MACD Signal Line 0.11
    MACD Histogram 0.07
    Fundamentals Value
    Market Cap 4.76 Billion
    Num Shares 256 Million
    EPS 2.28
    Price-to-Earnings (P/E) Ratio 8.16
    Price-to-Sales 0.68
    Price-to-Book 1.84
    Dividend 1.12
    Dividend Yield 6.02%
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 19.15
    Resistance 3 (R3) 19.19 19.06 19.06
    Resistance 2 (R2) 19.06 18.92 19.04 19.03
    Resistance 1 (R1) 18.83 18.83 18.77 18.79 19.00
    Pivot Point 18.70 18.70 18.66 18.68 18.70
    Support 1 (S1) 18.47 18.56 18.41 18.43 18.22
    Support 2 (S2) 18.34 18.47 18.32 18.19
    Support 3 (S3) 18.11 18.34 18.16
    Support 4 (S4) 18.07